Oncology Medication Market, Global Outlook and Forecast 2022-2028

February 2022 | 100 pages | ID: O5755A165AC1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Oncology Medication in Global, including the following market information:

Global Oncology Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oncology Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oncology Medication include Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncology Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oncology Medication Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy Medication
• Targeted Therapy Medication
• Immunotherapy Medication
• Hormonal Therapy Medication
• Others

Global Oncology Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oncology Medication Market Segment Percentages, by Application, 2021 (%)

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory or Lung Cancer
• Others

Global Oncology Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oncology Medication Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oncology Medication revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oncology Medication revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Celgene
• Novartis
• Bristol-Myers Squibb
• Johnson & Johnson
• Merck & Co.
• AstraZeneca
• Pfizer
• Amgen
• Takeda
• Astellas
• Ipsen
• Sanofi
• Bayer
• Biogen Idec

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oncology Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oncology Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ONCOLOGY MEDICATION OVERALL MARKET SIZE

2.1 Global Oncology Medication Market Size: 2021 VS 2028
2.2 Global Oncology Medication Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oncology Medication Players in Global Market
3.2 Top Global Oncology Medication Companies Ranked by Revenue
3.3 Global Oncology Medication Revenue by Companies
3.4 Top 3 and Top 5 Oncology Medication Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oncology Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Medication Players in Global Market
  3.6.1 List of Global Tier 1 Oncology Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oncology Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Oncology Medication Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy Medication
  4.1.3 Targeted Therapy Medication
  4.1.4 Immunotherapy Medication
  4.1.5 Hormonal Therapy Medication
  4.1.6 Others
4.2 By Type - Global Oncology Medication Revenue & Forecasts
  4.2.1 By Type - Global Oncology Medication Revenue, 2017-2022
  4.2.2 By Type - Global Oncology Medication Revenue, 2023-2028
  4.2.3 By Type - Global Oncology Medication Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oncology Medication Market Size, 2021 & 2028
  5.1.2 Blood Cancer
  5.1.3 Breast Cancer
  5.1.4 Gastrointestinal Cancer
  5.1.5 Prostate Cancer
  5.1.6 Respiratory or Lung Cancer
  5.1.7 Others
5.2 By Application - Global Oncology Medication Revenue & Forecasts
  5.2.1 By Application - Global Oncology Medication Revenue, 2017-2022
  5.2.2 By Application - Global Oncology Medication Revenue, 2023-2028
  5.2.3 By Application - Global Oncology Medication Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oncology Medication Market Size, 2021 & 2028
6.2 By Region - Global Oncology Medication Revenue & Forecasts
  6.2.1 By Region - Global Oncology Medication Revenue, 2017-2022
  6.2.2 By Region - Global Oncology Medication Revenue, 2023-2028
  6.2.3 By Region - Global Oncology Medication Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Oncology Medication Revenue, 2017-2028
  6.3.2 US Oncology Medication Market Size, 2017-2028
  6.3.3 Canada Oncology Medication Market Size, 2017-2028
  6.3.4 Mexico Oncology Medication Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Oncology Medication Revenue, 2017-2028
  6.4.2 Germany Oncology Medication Market Size, 2017-2028
  6.4.3 France Oncology Medication Market Size, 2017-2028
  6.4.4 U.K. Oncology Medication Market Size, 2017-2028
  6.4.5 Italy Oncology Medication Market Size, 2017-2028
  6.4.6 Russia Oncology Medication Market Size, 2017-2028
  6.4.7 Nordic Countries Oncology Medication Market Size, 2017-2028
  6.4.8 Benelux Oncology Medication Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Oncology Medication Revenue, 2017-2028
  6.5.2 China Oncology Medication Market Size, 2017-2028
  6.5.3 Japan Oncology Medication Market Size, 2017-2028
  6.5.4 South Korea Oncology Medication Market Size, 2017-2028
  6.5.5 Southeast Asia Oncology Medication Market Size, 2017-2028
  6.5.6 India Oncology Medication Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Oncology Medication Revenue, 2017-2028
  6.6.2 Brazil Oncology Medication Market Size, 2017-2028
  6.6.3 Argentina Oncology Medication Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oncology Medication Revenue, 2017-2028
  6.7.2 Turkey Oncology Medication Market Size, 2017-2028
  6.7.3 Israel Oncology Medication Market Size, 2017-2028
  6.7.4 Saudi Arabia Oncology Medication Market Size, 2017-2028
  6.7.5 UAE Oncology Medication Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Oncology Medication Major Product Offerings
  7.1.4 Roche Oncology Medication Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene Oncology Medication Major Product Offerings
  7.2.4 Celgene Oncology Medication Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Oncology Medication Major Product Offerings
  7.3.4 Novartis Oncology Medication Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Oncology Medication Major Product Offerings
  7.4.4 Bristol-Myers Squibb Oncology Medication Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Oncology Medication Major Product Offerings
  7.5.4 Johnson & Johnson Oncology Medication Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Merck & Co.
  7.6.1 Merck & Co. Corporate Summary
  7.6.2 Merck & Co. Business Overview
  7.6.3 Merck & Co. Oncology Medication Major Product Offerings
  7.6.4 Merck & Co. Oncology Medication Revenue in Global Market (2017-2022)
  7.6.5 Merck & Co. Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Oncology Medication Major Product Offerings
  7.7.4 AstraZeneca Oncology Medication Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Oncology Medication Major Product Offerings
  7.8.4 Pfizer Oncology Medication Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Amgen
  7.9.1 Amgen Corporate Summary
  7.9.2 Amgen Business Overview
  7.9.3 Amgen Oncology Medication Major Product Offerings
  7.9.4 Amgen Oncology Medication Revenue in Global Market (2017-2022)
  7.9.5 Amgen Key News
7.10 Takeda
  7.10.1 Takeda Corporate Summary
  7.10.2 Takeda Business Overview
  7.10.3 Takeda Oncology Medication Major Product Offerings
  7.10.4 Takeda Oncology Medication Revenue in Global Market (2017-2022)
  7.10.5 Takeda Key News
7.11 Astellas
  7.11.1 Astellas Corporate Summary
  7.11.2 Astellas Business Overview
  7.11.3 Astellas Oncology Medication Major Product Offerings
  7.11.4 Astellas Oncology Medication Revenue in Global Market (2017-2022)
  7.11.5 Astellas Key News
7.12 Ipsen
  7.12.1 Ipsen Corporate Summary
  7.12.2 Ipsen Business Overview
  7.12.3 Ipsen Oncology Medication Major Product Offerings
  7.12.4 Ipsen Oncology Medication Revenue in Global Market (2017-2022)
  7.12.5 Ipsen Key News
7.13 Sanofi
  7.13.1 Sanofi Corporate Summary
  7.13.2 Sanofi Business Overview
  7.13.3 Sanofi Oncology Medication Major Product Offerings
  7.13.4 Sanofi Oncology Medication Revenue in Global Market (2017-2022)
  7.13.5 Sanofi Key News
7.14 Bayer
  7.14.1 Bayer Corporate Summary
  7.14.2 Bayer Business Overview
  7.14.3 Bayer Oncology Medication Major Product Offerings
  7.14.4 Bayer Oncology Medication Revenue in Global Market (2017-2022)
  7.14.5 Bayer Key News
7.15 Biogen Idec
  7.15.1 Biogen Idec Corporate Summary
  7.15.2 Biogen Idec Business Overview
  7.15.3 Biogen Idec Oncology Medication Major Product Offerings
  7.15.4 Biogen Idec Oncology Medication Revenue in Global Market (2017-2022)
  7.15.5 Biogen Idec Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oncology Medication Market Opportunities & Trends in Global Market
Table 2. Oncology Medication Market Drivers in Global Market
Table 3. Oncology Medication Market Restraints in Global Market
Table 4. Key Players of Oncology Medication in Global Market
Table 5. Top Oncology Medication Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oncology Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oncology Medication Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oncology Medication Product Type
Table 9. List of Global Tier 1 Oncology Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oncology Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oncology Medication Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oncology Medication Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Oncology Medication Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oncology Medication Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oncology Medication Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Oncology Medication Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oncology Medication Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oncology Medication Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oncology Medication Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oncology Medication Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oncology Medication Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oncology Medication Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oncology Medication Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oncology Medication Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oncology Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oncology Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oncology Medication Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oncology Medication Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Oncology Medication Product Offerings
Table 32. Roche Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Oncology Medication Product Offerings
Table 35. Celgene Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Oncology Medication Product Offerings
Table 38. Novartis Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Oncology Medication Product Offerings
Table 41. Bristol-Myers Squibb Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Oncology Medication Product Offerings
Table 44. Johnson & Johnson Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 45. Merck & Co. Corporate Summary
Table 46. Merck & Co. Oncology Medication Product Offerings
Table 47. Merck & Co. Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Oncology Medication Product Offerings
Table 50. AstraZeneca Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Oncology Medication Product Offerings
Table 53. Pfizer Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Oncology Medication Product Offerings
Table 56. Amgen Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 57. Takeda Corporate Summary
Table 58. Takeda Oncology Medication Product Offerings
Table 59. Takeda Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 60. Astellas Corporate Summary
Table 61. Astellas Oncology Medication Product Offerings
Table 62. Astellas Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 63. Ipsen Corporate Summary
Table 64. Ipsen Oncology Medication Product Offerings
Table 65. Ipsen Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 66. Sanofi Corporate Summary
Table 67. Sanofi Oncology Medication Product Offerings
Table 68. Sanofi Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 69. Bayer Corporate Summary
Table 70. Bayer Oncology Medication Product Offerings
Table 71. Bayer Oncology Medication Revenue (US$, Mn), (2017-2022)
Table 72. Biogen Idec Corporate Summary
Table 73. Biogen Idec Oncology Medication Product Offerings
Table 74. Biogen Idec Oncology Medication Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Medication Segment by Type in 2021
Figure 2. Oncology Medication Segment by Application in 2021
Figure 3. Global Oncology Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oncology Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oncology Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Medication Revenue in 2021
Figure 8. By Type - Global Oncology Medication Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oncology Medication Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oncology Medication Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oncology Medication Revenue Market Share, 2017-2028
Figure 12. US Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oncology Medication Revenue Market Share, 2017-2028
Figure 16. Germany Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 17. France Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oncology Medication Revenue Market Share, 2017-2028
Figure 24. China Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 28. India Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oncology Medication Revenue Market Share, 2017-2028
Figure 30. Brazil Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oncology Medication Revenue Market Share, 2017-2028
Figure 33. Turkey Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oncology Medication Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck & Co. Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takeda Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Astellas Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ipsen Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sanofi Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Bayer Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Biogen Idec Oncology Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)